MannKind Corp
MNKD
#4917
Rank
NZ$3.01 B
Marketcap
NZ$9.83
Share price
-0.53%
Change (1 day)
-14.06%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): NZ$53.95 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.31 Billion. In 2024 the company made an earning of NZ$52.82 Million, an increase over its 2023 earnings that were of -NZ$17.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$53.95 M2.14%
2024 NZ$52.82 M-394.09%
2023 -NZ$17.97 Million-88.13%
2022 -NZ$0.16 Billion8%
2021 -NZ$0.15 Billion40.84%
2020 -NZ$99.46 Million10.7%
2019 -NZ$89.85 Million-40.16%
2018 -NZ$0.16 Billion-26.04%
2017 -NZ$0.21 Billion-193.33%
2016 NZ$0.21 B-134.11%
2015 -NZ$0.64 Billion85.72%
2014 -NZ$0.35 Billion3.6%
2013 -NZ$0.34 Billion12.79%
2012 -NZ$0.3 Billion5.58%
2011 -NZ$0.28 Billion-5.72%
2010 -NZ$0.3 Billion-22.51%
2009 -NZ$0.39 Billion-27.37%
2008 -NZ$0.53 Billion3.36%
2007 -NZ$0.51 Billion27.18%
2006 -NZ$0.4 Billion101.63%
2005 -NZ$0.2 Billion50.46%
2004 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Halozyme Therapeutics
HALO
NZ$1.29 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$36.08 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
NZ$39.96 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.2 Billion-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA